Clinical Trial

Austrian Left Atrial Appendage Closure Registry

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-01-17; most recent amendment 2024-11-19.
Trial Details
NCT Number NCT03409159
Lead Sponsor Medical University of Graz
Conditions Atrial Fibrillation, Left Atrial Appendage Closure
Enrollment 200 participants
Start Date 2017-05-16
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-11-21